Concepedia

Abdelali Lehraiki

AL

Statistics

Publications

9

Citations

851

H-Index

9

Active since

2009

Affiliations

Inserm(Current)

Université Paris Cité

Délégation Paris 7

CEA Paris-Saclay - Etablissement de Fontenay-aux-roses

Commissariat à l'Énergie Atomique et aux Énergies Alternatives

Abdelali Lehraiki is an author at Inserm specializing in developmental biology, medicine, and life sciences.

Publications per year

2009–2016

9

Publications

9

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance

Michaël Cerezo, Abdelali Lehraiki, Antoine Millet et al. · Cancer Cell · 2016 · 259 citations · Full text

, , +13

Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner

Michaël Cerezo, Mélanie Tichet, Patricia Abbe et al. · Molecular Cancer Therapeutics · 2013 · 216 citations

, , +17

Inhibition of Melanogenesis by the Antidiabetic Metformin

Abdelali Lehraiki, Patricia Abbe, Michaël Cerezo et al. · Journal of Investigative Dermatology · 2014 · 80 citations · Full text

, , +12

Phthalates Impair Germ Cell Number in the Mouse Fetal Testis by an Androgen- and Estrogen-Independent Mechanism

Abdelali Lehraiki, Chrystèle Racine, Andrée Krust et al. · Toxicological Sciences · 2009 · 77 citations · Full text

, , +17

Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib

Abdelali Lehraiki, Michaël Cerezo, Florian Rouaud et al. · Cell Discovery · 2015 · 70 citations · Full text

, , +17

1–5 of 9